查看購物車
  • Simplified Chinese
  • English
小分子藥物發現市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按治療領域、製程/階段和地理位置
市場調查報告書
商品編碼
1591417

小分子藥物發現市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按治療領域、製程/階段和地理位置

Small Molecule Drug Discovery Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Area, Process/Phase, and Geography
出版日期: | 出版商: The Insight Partners | 英文 140 Pages | 訂單完成後即時交付

價格

小分子藥物發現市場預計將從 2023 年的 509.3 億美元成長到 2031 年的 1,067.7 億美元；預計 2023-2031 年複合年成長率為 9.7%。蓬勃發展的製藥業、研發活動的激增以及外包傾向的不斷增強，正在促進小分子藥物發現市場的成長。然而，高昂的藥物開發成本阻礙了市場成長。此外，人工智慧在藥物發現中的日益採用預計將在未來幾年帶來新的小分子藥物發現市場趨勢。

2023年，北美佔據全球小分子藥物發現市場的主要佔有率。製藥和生物技術公司在發現新藥方面不斷增加的研究和開發、對藥品的投資不斷增加以及癌症的盛行率預計將加速北美小分子藥物發現市場的成長。美國是北美最發達的國家之一。心血管疾病和癌症等慢性疾病的盛行率不斷上升，主要推動了該國市場的成長。根據美國癌症協會的數據，到 2024 年，美國預計將有約 200 萬人患有新癌症病例，預計將有約 611,000 例死亡病例。由於這種情況，美國衛生系統在新型藥物分子的研發方面投入了大量資金。此外，強大的藥物管道以及小分子藥物治療領域的批准預計將推動該區域市場的發展。除了批准藥物數量的增加之外，對先進療法的認知不斷提高也可能是預測期內小分子藥物發現市場成長的原因。

加拿大小分子藥物發現市場的成長歸因於政府措施的增加和癌症盛行率的增加，以及主要參與者的策略性舉措。由於提供創新的治療選擇，加拿大人能夠應對各種醫療狀況。加拿大醫療保健中小分子藥物的日益普及可能會在未來幾年繼續推動市場成長。

根據加拿大政府的數據，就銷售額而言，該國在全球最大的醫藥市場中排名第九。創新製藥公司、藥品製造商、合約研究組織（CRO）和中小型生物製藥公司是如此巨大銷售價值的主要推動者。根據加拿大統計局 2020 年的數據，有 6,280 家公司在加拿大營運。醫藥業佔整個醫療保健產業的41%，研發業佔31%。因此，快速成長的製藥和生物製藥產業在加拿大產生了對小分子藥物發現的巨大需求。

增加小分子產品管線為未來提供市場機會

製藥業不斷發展，始終需要新的、創新的治療方法來治療各種慢性適應症。過去五年，小分子藥物的批准數量有所增加，因為它們對多種適應症有效。基於小分子候選藥物的產品線正在不斷成長，用於廣泛的治療應用，包括腫瘤學、高血壓、糖尿病和發炎性疾病。許多大大小小的製藥公司都在從事多種小分子藥物的開發。

針對各種適應症的小分子藥物不斷增加，反過來又促進了整個產業的藥物發現活動。

化合物名稱 化合物類型 公司名稱 臨床階段 適應症

PF-06821497 小分子輝瑞公司 1 期癌症

PF-06873600 小分子輝瑞公司第 1 期乳癌轉移

PF-06939999 小分子輝瑞公司 1 期實體瘤

PF-06952229 小分子輝瑞公司 1 期癌症

PF-06826647 小分子輝瑞公司 1 期潰瘍性結腸炎

PF-07038124 小分子輝瑞公司 1 期異位性皮膚炎

PF-06842874 小分子輝瑞公司 1 期肺動脈高壓

PF-06865571 小分子輝瑞公司 1 期非酒精性脂肪性肝炎 (NASH) 伴隨肝纖維化

PF-06882961 小分子輝瑞公司第 1 期糖尿病 2 型，肥胖

PF-07081532 小分子輝瑞公司第 1 期糖尿病 2 型，肥胖

R835 小分子 Rigel Pharmaceuticals, Inc. 第 1 期炎症

疾病

R552 小分子 Rigel Pharmaceuticals, Inc. 第 1 期炎症

疾病

SY-1425 小分子 Syros Pharmaceuticals, Inc. 2 期 AML

資料來源：公司新聞和 Insight 合作夥伴分析

小分子藥物發現市場：競爭格局與關鍵發展

Bristol-Myers Squibb Co、Merck KGaA、GSK Plc、Boehringer Ingelheim International GmbH、Thermo Fisher Scientific Inc、ICON Plc、Danaher Corp、Charles River Laboratories International Inc、Oncodesign Services 和 Revvity Inc 是小分子領域的主要公司之一藥物發現市場。

美國食品藥物管理局、疾病管制與預防中心 (CDC) 以及藥物開發研究中心是準備小分子藥物發現市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 關鍵見解。

第 3 章：研究方法

  • 二次研究。
  • 初步研究。
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：小分子藥物發現市場格局

  • 概述。
  • PEST 分析。

第 5 章：小分子藥物發現市場 - 主要市場動態

  • 小分子藥物發現市場 - 主要市場動態。
  • 市場促進因素。
    • 醫藥產業蓬勃發展，研發活動激增。
    • 越來越傾向外包。
  • 市場限制。
    • 藥物開發成本高
  • 市場機會。
    • 增加基於小分子的管道。
  • 未來趨勢。
    • 人工智慧在藥物發現的應用越來越廣泛。
  • 促進因素和限制的影響：

第 6 章：小分子藥物發現市場 - 全球市場分析

  • 小分子藥物發現市場收入，2021-2031。
  • 小分子藥物發現市場預測分析。

第 7 章：小分子藥物發現市場分析 - 按治療領域

  • 腫瘤學。
  • 中樞神經系統..
  • 心血管
  • 呼吸系統。
  • 骨科。
  • 免疫學。
  • 罕見疾病。
  • 其他治療領域。

第 8 章：小分子藥物發現市場分析 - 按過程或階段

  • 目標發現。
  • 目標驗證。
  • 潛在客戶的產生與完善
  • 臨床前開發

第 9 章：小分子藥物發現市場 - 地理分析

  • 北美。
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區。
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳洲
      • 亞太地區其他地區
  • 中東和非洲。
    • 中東和非洲
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 南非
      • 中東和非洲其他地區
  • 南美洲和中美洲。
    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地區

第 10 章：產業格局

  • 概述。

第 11 章：公司簡介

  • Bristol-Myers Squibb Co.
  • Merck KGaA.
  • GSK Plc.
  • Thermo Fisher Scientific Inc.
  • ICON Plc.
  • Danaher Corp.
  • Charles River Laboratories International Inc.
  • Oncodesign Services.
  • Revvity Inc.
  • Boehringer Ingelheim International GmbH.

第 12 章：附錄

Product Code: TIPRE00004774

The Small Molecule Drug Discovery market is anticipated to grow from US$ 50.93 billion in 2023 and is projected to reach US$ 106.77 billion by 2031; it is expected to register a CAGR of 9.7% during 2023-2031. Flourishing pharmaceutical industry with surge in R&D activities and growing inclination toward outsourcing are contributing to the small molecule drug discovery market growth. However, high drug development costs hamper market growth. Further, the growing adoption of artificial intelligence in drug discovery is expected to bring new small molecule drug discovery market trends in the coming years.

North America accounted for a major share of the global small molecule drug discovery market in 2023. The North America small molecule drug discovery market is segmented into the US, Canada, and Mexico. Increasing research and development by pharmaceutical and biotechnology companies in discovering novel drugs, growing investments in pharmaceuticals, and prevalence of cancer are among the factors that are projected to accelerate the growth of the North America small molecule drug discovery market. The US is one of the most developed countries in North America. The increasing prevalence of chronic diseases such as cardiovascular diseases and cancer primarily drives the market growth in the country. As per the American Cancer Society, in 2024, ~2 million people are projected to suffer from new cancer cases, and ~611,000 death cases are expected to be registered in the US. Owing to this scenario, the US health system witnesses massive investments in research and developments for novel drug molecules. Further, a strong drug pipeline, along with therapeutic area approvals for small molecule drugs, is expected to drive the regional market. Apart from the rising number of approved drugs, increasing awareness of advanced therapeutics is likely to be responsible for the growth of the small molecule drug discovery market during the forecast period.

The growth of the Canada small molecule drug discovery market is attributed to increasing government initiatives and growing cancer prevalence, as well as strategic initiatives by the major players. Canadians are able to deal with a variety of medical conditions due to the availability of innovative treatment options. The rising adoption of small molecule medicines in Canadian healthcare is likely to continue to boost the market growth over the coming years.

As per the Government of Canada, the country ranks ninth among the largest pharmaceutical markets in the world in terms of sales value. Innovative pharmaceutical companies, drug manufacturers, contract research organizations (CROs), and small- and medium-sized biopharmaceutical companies are among the major enablers of such a huge sales value. According to Statistics Canada 2020, 6,280 companies were operating in Canada. The pharmaceutical sector accounts for 41%, and the research and development sector accounts for 31% of its overall healthcare sector. Thus, the rapidly growing pharmaceutical and biopharmaceutical industries generate a huge demand for small molecule drug discovery in Canada.

Increasing Small Molecule-Based Pipeline to Provide Market Opportunities in Future

The pharmaceutical industry is continually evolving and there is always a need for new, innovative therapeutic approaches in the treatment of various chronic indications. Small molecule-based drug approvals have been increased in the past five years owing to their effectiveness against a wide range of indications. Small molecule drug candidate-based pipelines are growing for a wide range of therapeutic applications, including oncology, hypertension, diabetes, and inflammatory disorders. Many big and small pharmaceutical companies are engaged in the development of several small-molecule drugs.

The growing pipeline of small molecule-based drugs for various indications is, in turn, boosting drug discovery activities across the industry.

Compound Name Compound Type Company Name Clinical Phase Indication

PF-06821497 Small Molecule Pfizer Inc. Phase 1 Cancer

PF-06873600 Small Molecule Pfizer Inc. Phase 1 Breast Cancer Metastatic

PF-06939999 Small Molecule Pfizer Inc. Phase 1 Solid Tumors

PF-06952229 Small Molecule Pfizer Inc. Phase 1 Cancer

PF-06826647 Small Molecule Pfizer Inc. Phase 1 Ulcerative Colitis

PF-07038124 Small Molecule Pfizer Inc. Phase 1 Atopic Dermatitis

PF-06842874 Small Molecule Pfizer Inc. Phase 1 Pulmonary Arterial Hypertension

PF-06865571 Small Molecule Pfizer Inc. Phase 1 Non-alcoholic Steatohepatitis (NASH) with Liver Fibrosis

PF-06882961 Small Molecule Pfizer Inc. Phase 1 Diabetes Mellitus-Type 2, Obesity

PF-07081532 Small Molecule Pfizer Inc. Phase 1 Diabetes Mellitus-Type 2, Obesity

R835 Small Molecule Rigel Pharmaceuticals, Inc. Phase 1 Inflammatory

Disorders

R552 Small Molecule Rigel Pharmaceuticals, Inc. Phase 1 Inflammatory

Disorders

SY-1425 Small Molecule Syros Pharmaceuticals, Inc. Phase 2 AML

Source: Company News and The Insight Partner Analysis

Small Molecule Drug Discovery Market: Competitive Landscape and Key Developments

Bristol-Myers Squibb Co, Merck KGaA, GSK Plc, Boehringer Ingelheim International GmbH, Thermo Fisher Scientific Inc, ICON Plc, Danaher Corp, Charles River Laboratories International Inc, Oncodesign Services, and Revvity Inc are among the key companies operating in the small molecule drug discovery market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Centre for the Study of Drug Development are among the primary and secondary sources referred to while preparing the small molecule drug discovery market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance.
  • 1.2 Market Segmentation.

2. Executive Summary

  • 2.1 Key Insights.

3. Research Methodology

  • 3.1 Secondary Research.
  • 3.2 Primary Research.
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.1 Developing base number:
    • 3.2.2 Data Triangulation:
    • 3.2.3 Country level data:

4. Small Molecule Drug Discovery Market Landscape

  • 4.1 Overview.
  • 4.2 PEST Analysis.

5. Small Molecule Drug Discovery Market - Key Market Dynamics

  • 5.1 Small Molecule Drug Discovery Market - Key Market Dynamics.
  • 5.2 Market Drivers.
    • 5.2.1 Flourishing Pharmaceutical Industry with Surge in R&D Activities.
    • 5.2.2 Growing Inclination Toward Outsourcing.
  • 5.3 Market Restraints.
    • 5.3.1 High Drug Development Cost
  • 5.4 Market Opportunities.
    • 5.4.1 Increasing Small Molecule-Based Pipeline.
  • 5.5 Future Trends.
    • 5.5.1 Growing Adoption of Artificial Intelligence in Drug Discovery.
  • 5.6 Impact of Drivers and Restraints:

6. Small Molecule Drug Discovery Market - Global Market Analysis

  • 6.1 Small Molecule Drug Discovery Market Revenue (US$ Million), 2021-2031.
  • 6.2 Small Molecule Drug Discovery Market Forecast Analysis.

7. Small Molecule Drug Discovery Market Analysis - by Therapeutic Area

  • 7.1 Oncology.
    • 7.1.1 Overview.
    • 7.1.2 Oncology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Central Nervous System..
    • 7.2.1 Overview.
    • 7.2.2 Central Nervous System: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Cardiovascular
    • 7.3.1 Overview.
    • 7.3.2 Cardiovascular: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Respiratory.
    • 7.4.1 Overview.
    • 7.4.2 Respiratory: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Orthopedics.
    • 7.5.1 Overview.
    • 7.5.2 Orthopedics: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Immunology.
    • 7.6.1 Overview.
    • 7.6.2 Immunology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Rare Diseases.
    • 7.7.1 Overview.
    • 7.7.2 Rare Diseases: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.8 Other Therapeutic Areas.
    • 7.8.1 Overview.
    • 7.8.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)

8. Small Molecule Drug Discovery Market Analysis - by Process or Phase

  • 8.1 Target Discovery.
    • 8.1.1 Overview.
    • 8.1.2 Target Discovery: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Target Validation.
    • 8.2.1 Overview.
    • 8.2.2 Target Validation: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lead Generation and Refinement
    • 8.3.1 Overview.
    • 8.3.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Preclinical Development
    • 8.4.1 Overview.
    • 8.4.2 Preclinical Development: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)

9. Small Molecule Drug Discovery Market - Geographical Analysis

  • 9.1 North America.
    • 9.1.1 North America Small Molecule Drug Discovery Market Overview.
    • 9.1.2 North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.1.3 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.1.4 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.1.5 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.1.5.1 United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.1.1 United States: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.1.2 United States: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.1.5.2 Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.2.1 Canada: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.2.2 Canada: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.1.5.3 Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.3.1 Mexico: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.3.2 Mexico: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.2 Europe
    • 9.2.1 Europe Small Molecule Drug Discovery Market Overview.
    • 9.2.2 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.2.3 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.2.4 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.2.5 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.2.5.1 Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.1.1 Germany: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.1.2 Germany: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.2 France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.2.1 France: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.2.2 France: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.3 United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.3.1 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.3.2 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.4 Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.4.1 Italy: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.4.2 Italy: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.5 Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.5.1 Spain: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.5.2 Spain: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.6 Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.6.1 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.6.2 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.3 Asia Pacific.
    • 9.3.1 Asia Pacific Small Molecule Drug Discovery Market Overview.
    • 9.3.2 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.3.3 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.3.4 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.3.5 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.3.5.1 Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.1.1 Japan: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.1.2 Japan: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.2 China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.2.1 China: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.2.2 China: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.3 India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.3.1 India: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.3.2 India: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.4 South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.4.1 South Korea: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.4.2 South Korea: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.5 Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.5.1 Australia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.5.2 Australia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.6 Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.6.1 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.6.2 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.4 Middle East & Africa.
    • 9.4.1 Middle East & Africa Small Molecule Drug Discovery Market Overview.
    • 9.4.2 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.4.3 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.4.4 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.4.5 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.4.5.1 Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.1.1 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.1.2 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.2 United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.2.1 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.2.2 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.3 South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.3.1 South Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.3.2 South Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.4 Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.4.1 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.4.2 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.5 South & Central America.
    • 9.5.1 South & Central America Small Molecule Drug Discovery Market Overview.
    • 9.5.2 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.5.3 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.5.4 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.5.5 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.5.5.1 Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.1.1 Brazil: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.1.2 Brazil: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.5.5.2 Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.2.1 Argentina: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.2.2 Argentina: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.5.5.3 Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.3.1 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.3.2 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.

10. Industry Landscape

  • 10.1 Overview.

11. Company Profiles

  • 11.1 Bristol-Myers Squibb Co.
    • 11.1.1 Key Facts.
    • 11.1.2 Business Description.
    • 11.1.3 Products and Services.
    • 11.1.4 Financial Overview.
    • 11.1.5 SWOT Analysis.
    • 11.1.6 Key Developments.
  • 11.2 Merck KGaA.
    • 11.2.1 Key Facts.
    • 11.2.2 Business Description.
    • 11.2.3 Products and Services.
    • 11.2.4 Financial Overview.
    • 11.2.5 SWOT Analysis.
    • 11.2.6 Key Developments.
  • 11.3 GSK Plc.
    • 11.3.1 Key Facts.
    • 11.3.2 Business Description.
    • 11.3.3 Products and Services.
    • 11.3.4 Financial Overview.
    • 11.3.5 SWOT Analysis.
    • 11.3.6 Key Developments.
  • 11.4 Thermo Fisher Scientific Inc.
    • 11.4.1 Key Facts.
    • 11.4.2 Business Description.
    • 11.4.3 Products and Services.
    • 11.4.4 Financial Overview.
    • 11.4.5 SWOT Analysis.
    • 11.4.6 Key Developments.
  • 11.5 ICON Plc.
    • 11.5.1 Key Facts.
    • 11.5.2 Business Description.
    • 11.5.3 Products and Services.
    • 11.5.4 Financial Overview.
    • 11.5.5 SWOT Analysis.
    • 11.5.6 Key Developments.
  • 11.6 Danaher Corp.
    • 11.6.1 Key Facts.
    • 11.6.2 Business Description.
    • 11.6.3 Products and Services.
    • 11.6.4 Financial Overview.
    • 11.6.5 SWOT Analysis.
    • 11.6.6 Key Developments.
  • 11.7 Charles River Laboratories International Inc.
    • 11.7.1 Key Facts.
    • 11.7.2 Business Description.
    • 11.7.3 Products and Services.
    • 11.7.4 Financial Overview.
    • 11.7.5 SWOT Analysis.
    • 11.7.6 Key Developments.
  • 11.8 Oncodesign Services.
    • 11.8.1 Key Facts.
    • 11.8.2 Business Description.
    • 11.8.3 Products and Services.
    • 11.8.4 Financial Overview.
    • 11.8.5 SWOT Analysis.
    • 11.8.6 Key Developments.
  • 11.9 Revvity Inc.
    • 11.9.1 Key Facts.
    • 11.9.2 Business Description.
    • 11.9.3 Products and Services.
    • 11.9.4 Financial Overview.
    • 11.9.5 SWOT Analysis.
    • 11.9.6 Key Developments.
  • 11.10 Boehringer Ingelheim International GmbH.
    • 11.10.1 Key Facts.
    • 11.10.2 Business Description.
    • 11.10.3 Products and Services.
    • 11.10.4 Financial Overview.
    • 11.10.5 SWOT Analysis.
    • 11.10.6 Key Developments.

12. Appendix

  • 12.1 About The Insight Partners.
  • 12.2 Glossary of Terms.

List Of Tables

  • Table 1. Small Molecule Drug Discovery Market Segmentation.
  • Table 2. R&D Investments by Major Pharmaceutical Companies.
  • Table 3. Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 4. North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 5. North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 6. United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 7. United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 8. Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 9. Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 10. Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 11. Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 12. Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 13. Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 14. Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 15. Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 16. France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 17. France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 18. United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 19. United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 20. Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 21. Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 22. Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 23. Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 24. Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 25. Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 26. Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 27. Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 28. Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 29. Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 30. China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 31. China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 32. India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 33. India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 34. South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 35. South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 36. Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 37. Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 38. Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 39. Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 40. Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 41. Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 42. Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 43. Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 44. United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 45. United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 46. South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 47. South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 48. Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Area.
  • Table 49. Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 50. South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 51. South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 52. Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 53. Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 54. Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 55. Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 56. Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 57. Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million) - by Process or Phase.
  • Table 58. Recent Inorganic Growth Strategies in the Small Molecule Drug Discovery Market
  • Table 59. Glossary of Terms, Small Molecule Drug Discovery Market

List Of Figures

  • Figure 1. Small Molecule Drug Discovery Market Segmentation, by Geography.
  • Figure 2. PEST Analysis.
  • Figure 3. Impact Analysis of Drivers and Restraints.
  • Figure 4. Small Molecule Drug Discovery Market Revenue (US$ Million), 2021-2031.
  • Figure 5. Small Molecule Drug Discovery Market Share (%) - by Therapeutic Area (2023 and 2031)
  • Figure 6. Oncology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Central Nervous System: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cardiovascular: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Respiratory: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Orthopedics: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Immunology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Rare Diseases: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Other Therapeutic Areas: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Small Molecule Drug Discovery Market Share (%) - by Process or Phase (2023 and 2031)
  • Figure 15. Target Discovery: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Target Validation: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Lead Generation and Refinement: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Preclinical Development: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. North America: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. Europe: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 26. Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Asia Pacific: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 34. Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 46. South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. South & Central America: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 48. Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)